Pfizer Ups Covid-19 Vaccine Forecast as Sales More Than Double
Pfizer Inc. raised its forecast for sales of its Covid-19 vaccine this year to about $36 billion, a roughly 7%...
Johnson & Johnson
Moderna and J&J Covid-19 Boosters, Mixing and Matching Authorized by the FDA
U.S. health regulators significantly widened the nation’s Covid-19 booster campaign, clearing use of extra doses of Moderna Inc. and Johnson...
Higher Sales Across Divisions Lift Johnson & Johnson as Healthcare Sector Recovers
Johnson & Johnson’s JNJ 2.55% sales climbed in the latest quarter compared with the same stretch of last year, reflecting...
WSJ News Exclusive | FDA Delays Moderna Covid-19 Vaccine for Adolescents to Review Rare Myocarditis Side Effect
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...
Johnson & Johnson’s Top Scientist to Depart
Johnson & Johnson’s JNJ -0.42% top scientist, who oversaw a turnaround in the company’s pharmaceutical unit and the development of...
J&J Says Covid-19 Booster Shots After Eight Months Supported by Data
Johnson & Johnson said Wednesday that a second dose of its Covid-19 vaccine was found in a study to generate...
